Lab
Hypereosinophilic Syndrome
search
Hypereosinophilic Syndrome
See Also
Eosinophilia
Eosinophilia-Myalgia Syndrome
Complete Blood Count
Definitions
Hypereosinophilic Syndrome
Group of conditions with
Eosinophil
s >1500 cells/uL >6 months with organ involvement and no cause found
Epidemiology
Gender: Men are 10 fold more likely to be affected than women
Age: 20 to 50 years old
Symptoms
Symptoms vary by specific Hypereosinophilic Syndrome
Fever
Cardiopulmonary
Angioedema
Cough
Shortness of Breath
Chest Pain
Rheumatologic
Myalgias
Arthralgia
s
Neurologic
Vertigo
Weakness
Blurred Vision
Skin
Rash
Pruritus
Imaging
Chest XRay
Lung
infiltrates seen in >30% of cases
Pleural Effusion
s
Labs
Complete Blood Count
(CBC)
Eosinophilia
with >=1500 cells/uL (all cases, defining feature)
Thrombocytopenia
(>5% of cases)
Anemia
Diagnosis
Absolute
Eosinophil Count
>=1500 cells/uL for 6 months or more AND
No cause identified AND
Organ involvement with
Eosinophil
ic tissue infiltration
Differential Diagnosis
See
Eosinophilia
Familial Hypereosinophilic Syndrome (rare)
Myeloproliferative Hypereosinophilic Syndrome (e.g. myeloid
Leukemia
, See
Eosinophilia
)
Lymph
ocytic Hypereosinophilic Syndrome
Increased Interkeukin-5 (
Cytokine
)
Management
First-Line Management
Corticosteroid
s (e.g.
Prednisone
)
Second-Line Management Options (
Corticosteroid
refractory Hypereosinophilia)
Hydroxyurea
Interferon
-Alpha
Imatinab (
Gleevec
)
Third-Line Refractory Cases
Cyclosporin
Bone Marrow Transplant
Other Specific Management
Myeloproliferative Hypereosinophilic Syndrome
Imatinab (
Gleevec
) is indicated in FIP1L1/PDGFRA Fusion
Gene
Complications
Angioedema
Arthritis
Congestive Heart Failure
,
Myocarditis
or
Restrictive Cardiomyopathy
Deep Vein Thrombosis
Anemia
Hepatomegaly
Splenomegaly
Resources
Hypereosinophilic Syndrome (NIH)
https://rarediseases.info.nih.gov/diseases/2804/hypereosinophilic-syndrome
References
Mahmoudi (2014)
Immunology
Made Ridiculously Simple, MedMaster, Miami, FL
Type your search phrase here